DOCSLIB.ORG

212 17 Mechanical Ileus Associated Feeding Jejunostomy After Liver

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
212 17 Mechanical Ileus Associated Feeding Jejunostomy After Liver The 34th Congress of The Korean Association of Hepato-Biliary-Pancreatic Surgery cation after organ transplantation which requires im- patterns of complication in the patients with mechan- munosuppressive therapy. Posttransplant immunosu- ical ileus after the feeding jejunostomy after liver ppressive medications result in decreased immune sur- transplantation can be introduced. veillance against malignant cells and increase the risk Patients and Methods: We reviewed the cases of of malignancies mediated by various viruses. In this three patients; first a 62-year-old woman who pre- study, we tried to investigate the incidence patterns sented with toxic hepatitis and received living liver and treatments of de novo malignancy after liver transplantation, second a 68-year-old woman who pre- transplantation (LT), especially mainly after living do- sented with acute on chronic HBV hepatitis and re- nor liver transplantation. ceived living liver transplantation emergently and, Methods: Between August 1992 to December 2008, third a 16-year-old woman who presented with toxic 2174 LT were performed, living donor liver trans- hepatitis on the drug and received emergent cadaveric plantation cases were 1879 and deceased donor liver liver transplantation. Their medical records were retro- transplantation cases were 295. spectively reviewed. Results: Among them, 35 patients (1.6%) revealed de Results: One patient showed self limited recovery novo malignancies. In this single-center series, the in- with hydration and restricting diet. The other patients cidence rate of de novo malignancy was rather low required emergent operation. The performing of feed- (1.6%). The patterns of de novo malignancy were also ing jejunostomy during the liver transplantation must different from those in western countries. The com- be considered seriously because of its urgent mon malignancies were stomach cancer and colon complication. cancer in this series, but skin cancer, lymphoma and lung cancer were more common in western countries. Conclusion: In our institution, posttransplant peri- 18 odic checkup was done in every 1-year basis, espe- cially focused on common malignancies in Korea. The periodic checkup list always includes gastrofiberscopy Unusual Type of Hepatic Hemangioma for early detection of stomach cancer. The common Mimicking Hepatocellular Carcinoma: malignancies usually occur in transplant patients at an High-Flow Pattern on MRI earlier age than in the general population. Thus year- Department of Surgery, Chonnam National University ly screening checkup may be beneficial regardless the Medical School, Korea age of liver recipients. Eunkyu Park, Yang Seok Koh, Young Hoe Hur, Ho Hyun Kim, Jin Shick Seoung, Jung Chul Kim, Hyun Jong Kim, Chol Kyoon Cho 17 Introduction: The hepatic hemangiomas could be Mechanical Ileus Associated Feeding distinguished with hepatocellular carcinoma (HCC) in Jejunostomy after Liver Transplantation the point of showing bright signal intensity on un- enhanced T2-weighted imaging of MRI. However, Department of Hepatobiliary Surgery and Liver some atypical hemangiomas, especially high-flow he- Transplantation, University of Ulsan College of Medicine and mangiomas, can display rapid, intense homogeneous Asan Medical Center, Seoul, Korea arterial enhancement and can show isointense or CS Park, SG Lee, S Hwang, KH Kim, CS Ahn, slightly hyperintense signal during the equilibrium DB Moon, TY Ha, GW Song, DH Jung, GC phase of liver MRI using gadoxetic acid-enhancement Park, YD Yoo, PJ Park, YI Choi, SY Yoon, JM MRI. Therefore, these early enhancing types of he- Namgung, SW Jung, HW Park, HJ Lee mangiomas can mimic hypervascular hepatic tumors, such as HCC. We report the case of high-flow hepatic Background: There are many complication associated hemangioma confused with HCC. with feeding jejunostomy with liver transplantation. Case: A 65-year-old male presented our hospital with Mechanical ileus is also often seen after the feeding liver mass detected by heath survey and he had no jejunostomy after liver transplantation. Three different history of hepatitis and liver cirrhosis. Enhanced com- 212 Poster puted tomography showed early enhancing and early washed out well marginated exophyting solid mass in 19 left lateral segment of liver. Serum alpha-fetoprotein was within normal range and hepatitis viral marker Hepatic Resection for Initially Inoperable indicated negative for viral hepatitis. This hepatic le- Hepatocellular Carcinoma (HCC); Pretreated sion was showed as slightly low signal intensity on T1 weighed imaging and heterogeneous signal in- Hepatic Aterial Infusion of Chemotherapy tensity on T2 weiged imaging of MRI. Moreover it (HAIC) was well enhanced at arterial phase and washed out Division of Hepatobiliary Surgery and Liver Transplantation, at delayed phase. So he was diagnosed HCC and un- Department of Surgery, Asan Medical Center, University of derwent wedge resection of left lateral segment of Ulsan College of Medicine, Korea liver. At surgery, there was 3 cm sized well margi- Gilchun Park, Donghwan Jung, Giwon Song, nated soft mass in the liver. Postoperative Histology Taeyong Ha, Dukbok Moon, Kihun Kim, and immunohistochemistry revealed that the hepatic Chulsoo Ahn, Shin Hwang, Sunggyu Lee mass was not HCC but hemangioma. The post- operative course was uneventful and he discharged 1 Introduction: Treatment of advanced HCC remains week after surgery. a significant problem for clinicians. Numerous clinical Discussion: Problematic issues might occur in the studies have shown that HAIC provides moderate differentiation of high-flow hemangiomas from HCC therapeutic efficacy with substantially favorable tox- after gadoxetic acid–enhanced MRI if the lesion shows icity profiles in selected patients groups with ad- a pseudo washout sign. A high-flow hemangioma on vanced HCC. We present our experience of two pa- gadoxetic acid–enhanced MRI could show bright signal tients with initially inoperable advanced HCC who on a T2-weighted image; a rapid, intense homoge- underwent hepatic resection after pretreated HAIC. neous or dominant portion enhancement on the arte- Case Report: First case was 45 year old man who rial phase; or a pseudo washout pattern on the equili- had multiple HCC with portal vein tumor thrombus brium phase. The pseudo washout sign was not con- (PVTT) in both lobs of liver at Dec. 2009. From Jan. sidered a true contrast wash out as occurs in HCC. 2010 to Jun. 2010, HAIC with 5-FU, mitomycin, epi- Rather, it was thought to be due to contrast uptake rubicin was performed six cycles and transarterial che- in the surrounding normal liver parenchyma; the le- moembolization (TACE) once. At Jan. 2011, he under- sion itself might have low signal intensity. High-flow went partial hepatectomy uneventfully and discharged hemangiomas should be considered when the follow- well. Second case was 51 year old woman who had ing are observed: bright signal intensity on T2-weigh- huge HCC with PVTT in left lobe at Oct. 2008. She ted imaging, arterial-phase dominant enhancement, took HAIC treatment with 5-FU, cisplatin six cycles pseudo washout sign during the equilibrium phase, till Apr. 2009 in spite of favorable toxicity frequent perilesional arterioportal shunt, and iso- (leukopenia). Left trisectionectomy and caudate lobec- intensity or slightly increased signal intensity on the tomy with PVTT thrombectomy was performed subtraction images between the unenhanced phase and successfully. Until now, there is no evidence of dis- the equilibrium phase. ease recurrence. Conclusions: For initially unresectable HCC without liver cirrhosis, HAIC may be an effective treatment modality. We suggest that more clinical studies should be undertaken to explore the use of HAIC for ad- vanced HCC patients. 213.
Load more

Recommended publications
  • Routine Use of Feeding Jejunostomy in Pancreaticoduodenectomuy: A
    Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 95 JuneSeptember 2020 2020 doi:10.20944/preprints202006.0114.v1 doi:10.20944/preprints202006.0114.v2 Routine use of Feeding Jejunostomy in Pancreaticoduodenectomuy: A Metaanalysis. DR.Bhavin Vasavada Consultant HepatoPancreaticobiliary and Liver Transplant Surgeon, Shalby Hospitals, Ahmedabad. Email: [email protected] Dr.Hardik Patel Consultant HepatoPancreaticobiliary and Liver Transplant Surgeon, Shalby Hospitals, Ahmedabad. Conflict of Interests: none. Funding disclosure: none. Abbreviations: Post operative pancreatic fistula (POPF), total parentral nutrition (TPN), Surgical site infections. (SSI) Keywords: Pancreaticoduodenectomy; feeding jejunostomy; morbidity; mortality Abstract: Aims and objectives: The primary aim of our study was to evaluate morbidity and mortality following feeding jejunostomy in pancreaticoduodenectomy compared to the control group. We © 2020 by the author(s). Distributed under a Creative Commons CC BY license. Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 95 JuneSeptember 2020 2020 doi:10.20944/preprints202006.0114.v1 doi:10.20944/preprints202006.0114.v2 also evaluated individual complications like delayed gastric emptying, post operative pancreatic fistula, superficial and deep surgical site infection. We also looked for time to start oral nutrition and requirement of total parentral nutrition. Material and Methods: The study was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement and MOOSE guidelines. [9,10]. We searched pubmed, cochrane library, embase, google scholar with keywords like “feeding jejunostomy in pancreaticodudenectomy”, “entral nutrition in pancreaticoduodenectomy, “total parentral nutrition in pancreaticoduodenectomy’, “morbidity and mortality following pancreaticoduodenectomy”. Two independent authors extracted the data (B.V and H.P). The meta-analysis was conducted using Open meta-analysis software.
    [Show full text]
  • Laparoscopic Truncal Vagotomy and Gatrojejunostomy for Pyloric Stenosis
    ORIGINAL ARTICLE pISSN 2234-778X •eISSN 2234-5248 J Minim Invasive Surg 2015;18(2):48-52 Journal of Minimally Invasive Surgery Laparoscopic Truncal Vagotomy and Gatrojejunostomy for Pyloric Stenosis Jung-Wook Suh, M.D.1, Ye Seob Jee, M.D., Ph.D.1,2 Department of Surgery, 1Dankook University Hospital, 2Dankook University School of Medicine, Cheonan, Korea Purpose: Peptic ulcer disease (PUD) remains one of the most prevalent gastrointestinal diseases and Received January 27, 2015 an important target for surgical treatment. Laparoscopy applies to most surgical procedures; however Revised 1st March 9, 2015 its use in elective peptic ulcer surgery, particularly in cases of pyloric stenosis, has not been popular. 2nd March 28, 2015 The aim of this study was to describe the role of laparoscopic surgery and an easily performed Accepted April 20, 2015 procedure for pyloric stenosis. We accordingly performed laparoscopic truncal vagotomy with gastrojejunostomy in 10 consecutive patients with pyloric stenosis. Corresponding author Ye Seob Jee Methods: Data were collected prospectively from all patients who underwent laparoscopic truncal Department of Surgery, Dankook vagotomy with gastrojejunostomy from August 2009 to May 2014 and reviewed retrospectively. University Hospital, Dankook Results: A total of 10 patients underwent laparoscopic trucal vagotomy with gastrojejunostomy for University School of Medicine, 119, peptic ulcer obstruction from August 2009 to May 2014 in ○○ university hospital. The mean age was Dandae-ro, Dongnam-gu, Cheonan 62.6 (±16.4) years old and mean BMI was 19.3 (±2.5) kg/m2. There were no conversions to open 330-714, Korea surgery and no occurrence of intra-operative complications.
    [Show full text]
  • Tube Feeding Protocol: Supporting an Individual with a Feeding Tube
    Tube Feeding Protocol: Supporting an Individual with a Feeding Tube Introduction Some people may be unable to take foods or fluids by mouth due to dysphagia. Others may require supplementation because they are unable to take sufficient foods or fluids by mouth, and formula delivered through a feeding tube may provide them with much needed additional nutrients. It is helpful if guidelines (A Tube Feeding Protocol) are in place prior to the need for this intervention. Below are some suggested guidelines for supporting an Individual with a feeding tube. Information to be documented by the physician The reason (medical diagnosis) requiring feeding tube insertion Type of feeding tube inserted Types of feeding tubes The Nasogastric Tube (NG tube): Passed into either nostril, down the esophagus and into the stomach. This is used for short term feedings. The Gastrostomy tube (G - tube or PEG): Surgically placed through the abdominal wall into the stomach. The tube will be located below the rib cage and to the left. The Jejunostomy tube (J - tube or PEJ): Surgically implanted in the upper portion of the jejunum (Part of the small intestine.) The tube will be located lower in the abdomen and more toward the center than the G – tube. Feedings through a J – tube must always be by pump. The Gastrostomy-Jejunostomy (GJ - tube): Surgically placed in the stomach, like the G – tube, but the tubing is longer, the end is in the jejunum, and there are two ports. Feeding technique Feeding techniques Bolus: A set amount of formula is given over a short period of time via syringe.
    [Show full text]
  • Laparoscopic Witzel Jejunostomy
    [Downloaded free from http://www.journalofmas.com on Wednesday, February 12, 2020, IP: 93.55.127.222] How I do It Laparoscopic Witzel jejunostomy Marco Lotti1, Michela Giulii Capponi2, Denise Ferrari2, Giulia Carrara1, Luca Campanati2, Alessandro Lucianetti2 1Advanced Surgical Oncology Unit, Department of General Surgery 1, Papa Giovanni XXIII Hospital, Bergamo, Italy, 2Department of General Surgery 1, Papa Giovanni XXIII Hospital, Bergamo, Italy Abstract The placement of a feeding jejunostomy can be indicated in malnourished patients with gastric and oesophagogastric junction cancer to allow for enteral nutritional support. In these patients, the jejunostomy tube can be suitably placed at the time of staging laparoscopy. Several techniques of laparoscopic jejunostomy (LJ) have been described, yet the Witzel approach remains neglected, due to the perceived difficulty of suturing the bowel around the tube and securing them to the abdominal wall. Here, we describe a novel technique for LJ, using a single barbed suture for securing the bowel and tunnelling the jejunostomy catheter according to the Witzel approach. Keywords: Enteral nutrition, oesophagogastric junction cancer, gastric cancer, jejunostomy, laparoscopic jejunostomy Address for correspondence: Dr. Marco Lot, Advanced Surgical Oncology Unit, Ospedale Papa Giovanni XXIII, Piazza OMS, 1, 24127 Bergamo, Italy. E‑mail: [email protected] Received: 17.10.2019, Accepted: 11.11.2019, Published: 11.02.2020 INTRODUCTION use of peel-away introducers, sealing the entry site with barbed
    [Show full text]
  • Short Bowel, Short Answer?
    478 Nightingale 8 Van Doorn L, Figueiredo C, Sanna R, et al. Clinical relevance of the cagA, 10 Yamaoka Y, Kodama T, Kashima K, et al. Variants of the 3' region of the vacA and iceA status of Helicobacter pylori. Gastroenterology 1998;115:58–66. cagA gene in Helicobacter pylori isolates from patients with diVerent H. 9 Rudi J, Kolb C, Maiwald M, et al. Diversity of Helicobacter pylori vacA and pylori-associated diseases. J Clin Microbiol 1998;36:2258–63. cagA genes and relationship to VacA and CagA protein expression, 11 Blaser MJ. Helicobacters are indigenous to the human stomach: duodenal cytotoxin production and associated diseases. J Clin Microbiol 1998;36: ulceration is due to changes in gastric microecology in the modern era. Gut 944–8. 1998;43:721–7. See article on page 559 Short bowel, short answer? from their stoma.14 This is because of loss of normal daily intestinal secretions (about 4 litres/24 hours), rapid gastric emptying and rapid small bowel transit.15 If a patient has less than 100 cm jejunum remaining and a stoma he/she is The paper by Jeppsen et al (see page 559) shows that likely, as a minimum, to need long term parenteral saline.14 glucagon-like peptide-2 (GLP-2) concentrations are low in This requirement does not reduce with time.3 Patients patients lacking an ileum and colon. This is not an with a retained colon do not have these problems and, unexpected finding as the L cells that produce GLP-2 are owing to functional adaptation, nutrient absorption situated in the ileum and colon.
    [Show full text]
  • Pancreaticoduodenectomy After Roux-En-Y Gastric Bypass: a Novel Reconstruction Technique
    6 Technical Note Pancreaticoduodenectomy after Roux-en-Y Gastric Bypass: a novel reconstruction technique Malcolm Han Wen Mak, Vishalkumar G. Shelat Department of General Surgery, Tan Tock Seng Hospital, Singapore, Singapore Correspondence to: Dr. Malcolm Han Wen Mak. Department of General Surgery, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore. Email: [email protected] Abstract: The obesity epidemic continues to increase around the world with its attendant complications of metabolic syndrome and increased risk of malignancies, including pancreatic malignancy. The Roux-en-Y gastric bypass (RYGB) is an effective bariatric procedure for obesity and its comorbidities. We describe a report wherein a patient with previous RYGB was treated with a novel reconstruction technique following a pancreaticoduodenectomy (PD). A 59-year-old male patient with previous history of RYGB was admitted with painless progressive jaundice. Imaging revealed a distal common bile duct stricture and he underwent PD. There are multiple options for reconstruction after PD in patients with previous RYGB. The two major decisions for pancreatic surgeon are: (I) resection/preservation of remnant stomach and (II) resection/ preservation of original biliopancreatic limb. This has to be tailored to the patient based on the intraoperative findings and anatomical suitability. In our patient, the gastric remnant was preserved, and distal part of original biliopancreatic limb was anastomosed to the stomach as a venting anterior gastrojejunostomy. A distal loop of small bowel was used to reconstruct the pancreaticojejunostomy and hepaticojejunostomy and further distally a new jejunojejunostomy performed. The post-operative course was uneventful, and the patient was discharged on 7th day.
    [Show full text]
  • Focus on Laparoscopic Feeding Jejunostomy Operative Technique
    Surgical Technique World Journal of Surgery and Surgical Research Published: 31 Mar, 2020 Focus on Laparoscopic Feeding Jejunostomy Operative Technique Sorin Cimpean1*, Byabene Gloire A Dieu2 and Guy Bernard Cadiere1 1Department of Digestive Surgery, Saint Pierre University Hospital, Brussels, Belgium 2Department of Surgery, Panzi Hospital, Democratic Republic of the Congo Abstract The feeding jejunostomy placement is a surgical operation in which the patient is nourished through a feeding tube placed in the jejunum. Laparoscopic jejunostomy feeding tube placement can be standardized due to the regular anatomy. We developed a technique by laparoscopic approach a serosal tunnel (according to Witzel open technique) of the feeding tube using accessible materials. Introduction The feeding jejunostomy placement is a surgical operation in which the patient is nourished through a feeding tube placed in the jejunum, the first part of the small bowel. The first to accomplish a jejunostomy for nutritional purposes was Bush in 1858 in a patient with non-operable gastric cancer [1]. In 1891 Witzel described the most well-known technique for jejunostomy, and it has undergone diverse modification, such as those adopted by Coffey and Albert. A definitive jejunostomy is that done by the Roux-en-Y technique [2]. By 1990 minimal invasive surgery had appeared, and diverse options for jejunostomy by laparoscopy were described [3-8]. The feeding tube is a tube that requires an opening to be created between the skin of the abdomen and the wall of the jejunum. Connected directly to the patient's digestive tract, the feeding tube provides water, nutrients, and medication if needed. Feeding jejunostomy is essential when a patient is unable to have an oral alimentation.
    [Show full text]
  • Intestinal Transplantation
    The new england journal of medicine review article Current Concepts Intestinal Transplantation Thomas M. Fishbein, M.D. From the Georgetown Transplant Institute, he results of intestinal transplantation have improved over Georgetown University Hospital, Wash- the past decade. During this period, the number of intestinal transplant pro- ington, DC. Address reprint requests to 1 Dr. Fishbein at the Georgetown Trans- cedures performed in North America has increased by a factor of three. In plant Institute, 2 Main, Georgetown Uni- T 2008, a total of 185 intestinal transplantations were performed in the United States, versity Hospital, 3800 Reservoir Rd. NW, and 221 patients were registered on the waiting list as of June 2009 (http://optn. Washington, DC 20007, or at tmf8@gunet. georgetown.edu. transplant.hrsa.gov). Early attempts at transplantation were hindered by technical and immunologic complications that led to graft failure or death. As a result of recent N Engl J Med 2009;361:998-1008. surgical advances, control of acute cellular rejection, and a decrease in lethal infec- Copyright © 2009 Massachusetts Medical Society. tions, the rate of patient survival at 1 year now exceeds 90% at experienced centers. Although long-term follow-up data are still lacking, the role of intestinal transplan- tation in the treatment of patients with gut failure is becoming clearer. Parenteral nutrition is currently the primary maintenance therapy for patients in whom intestinal absorptive function has failed. Transplantation is offered to patients with irreversible gut failure who have one of three problems: complications of par- enteral nutrition, an inability to adapt to the quality-of-life limitations posed by in- testinal failure, or a high risk of death if the native gut is not removed (as in the case of unresectable mesenteric tumors or chronic intestinal obstruction).
    [Show full text]
  • Enteral Nutrition in Pancreaticoduodenectomy: a Literature Review
    Nutrients 2015, 7, 3154-3165; doi:10.3390/nu7053154 OPEN ACCESS nutrients ISSN 2072-6643 www.mdpi.com/journal/nutrients Review Enteral Nutrition in Pancreaticoduodenectomy: A Literature Review Salvatore Buscemi 1,2,†,*, Giuseppe Damiano 3, Vincenzo D. Palumbo 2,3,4, Gabriele Spinelli 2, Silvia Ficarella 2, Giulia Lo Monte 5, Antonio Marrazzo 2 and Attilio I. Lo Monte 2,3,† 1 School of Oncology and Experimental Surgery, University of Palermo, via Del Vespro 129, 90127 Palermo, Italy 2 Department of Surgical, Oncological and Dentistry Studies, University of Palermo, via Del Vespro 129, 90127 Palermo, Italy; E-Mails: [email protected] (V.D.P.); [email protected] (G.S.); [email protected] (S.F.); [email protected] (A.M.); [email protected] (A.I.L.M.) 3 “P.Giaccone”, University Hospital, School of Medicine, School of Biotechnology, University of Palermo, via Del Vespro 129, 90127 Palermo, Italy; E-Mail: [email protected] 4 School of Surgical Biotechnology and Regenerative Medicine in Organ Failure, University of Palermo, via Del Vespro 129, 90127 Palermo, Italy 5 School of Biotechnology, University of Palermo, via Del Vespro 129, 90127 Palermo, Italy; E-Mail: [email protected] † These authors contributed equally to this work. * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +39 3357593376. Received: 30 November 2014 / Accepted: 15 April 2015 / Published: 30 April 2015 Abstract: Pancreaticoduodenectomy (PD) is considered the gold standard treatment for periampullory carcinomas. This procedure presents 30%–40% of morbidity. Patients who have undergone pancreaticoduodenectomy often present perioperative malnutrition that is worse in the early postoperative days, affects the process of healing, the intestinal barrier function and the number of postoperative complications.
    [Show full text]
  • COMPLICATIONS of Bile Duct Recon
    Biliary Tract Complications in Liver Transplantation Under Cyclosporin-Steroid Therapy S. Iwatsuki, B. W. Shaw, Jr., and T. E. Starzl OMPLICATIONS of bile duct recon­ tube (usually infant feeding tube) was used as a stent. one C struction in liver transplantation are end passing through the papilla of Vater into the duode­ num (choledocho-choledochostomy with straight tube more frequent than those of vascular anasto­ stent. C-C-S), moses.I. 2 In earlier times, unrecognized bile End-to-side choledocho-jejunostomy in Roux-en-Y duct obstruction was frequently mistaken for with a straight tube stent (C-J-S) became the first choice graft rejection, and unwise decisions to when the recipient's bile duct was absent (in biliary increase immunosuppression often resulted in atresia) or diseased (in sclerosing cholangitis. bile duct cancer. or secondary biliary cirrhosis). When the donor's fatal septic complications. In other cases, bil­ common bile duct was used for bile duct reconstruction. iary leakage and peritonitis in the early post­ the gallbladder was always removed, operative period limited the adequate use of Cholecysto-jejunostomy in Roux-en-Y (Cy-J). tube immunosuppression, resulting in acute graft cholecystostomy. or tube choledochostomy were used only rejection superimposed on serious septic bil­ when the operation was so difficult and the patient was so unstable that better bile duct reconstruction could not be iary peritonitis. performed. The problems caused by biliary complica­ tions under conventional immunosuppression Case Materials have been reported in our series I and in the During the 29 months between March 1980 and July Cambridge series.2 These, directly or indirect­ 1982.78 patients received 90 orthotopic liver transplanta­ ly, caused death in many cases.
    [Show full text]
  • Appendix 10: Administering Drugs Via Feeding Tubes
    Appendix 10: Administering drugs via feeding tubes Administering drugs via feeding tubes is generally an unlicensed activity. There is little published data and most recommendations are theoretical and/or based on local policy. An alternative licensed option may therefore be preferable, e.g. rectal or parenteral formulations. However, if given by tube, there is a range of possibilities (Figure A10.1). Guidance should be sought from a pharmacist regarding which option is feasible or most appropriate. There are several types of feeding tubes (Box A10.A). These can be further classified according to lumen size (French gauge), number of lumens (single or multiple) and length of use (short- term, long-term/fixed). Figure A10.1 4-step ladder for drug administration by feeding tubesa Injectable formulation via tube Extemporaneous oral solution/suspension prepared by local pharmacy Crushed capsule/tablet contents fully dispersed Commercial oral solution/suspension or dispersible tablet a. Step 1 is the preferred option; for further explanation, see Choosing a suitable formulation. Box A10.A Main types of feeding tubes Nasogastric (NG), inserted into the stomach via the nose. Nasojejunal (NJ), inserted into the jejunum via the nose. Percutaneous endoscopic gastrostomy (PEG), inserted into the stomach via the abdominal wall. Percutaneous endoscopic jejunostomy (PEJ), inserted into the jejunum via the abdominal wall. Percutaneous endoscopic gastro-jejunostomy (PEGJ), inserted into the jejunum via the abdominal wall and through the stomach. © 2002 Palliativedrugs.com Ltd In addition to the general guidance (Box A10.B), the following should be considered when giving drugs via feeding tubes: • sterility with jejunal tube, use sterile water because the acid barrier in the stomach is bypassed; 1 some centres use an aseptic technique to reduce the risk of infective diarrhoea • site of drug delivery with jejunal tubes, absorption may be unpredictable because the tube may extend beyond the main site of absorption of the drug, e.g.
    [Show full text]
  • Feeding Tube
    When you have a Feeding Tube A guide for you, family and friends 1 Tube Feeding Important Information . This book belongs to: _________________________________ Doctor who put tube in: _______________________________ Family Doctor: ________________________________________ Dietitian: _____________________________________________ Nurse: ________________________________________________ Pharmacy: ____________________________________________ Specialty Food Shop: __________________________________ Equipment Supplier: ___________________________________ Formula Supplier: ______________________________________ Other Supplies: ________________________________________ Other Information: _____________________________________ Copyright: ©1995-2012 All rights reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted, in any form or by any means, electronic, mechanical, photocopying or otherwise, without the prior permission of St. Joseph’s Healthcare Hamilton, Hamilton, Ontario, Canada. For more information contact: St. Joseph’s Healthcare Hamilton, Nutrition Services Department, 50 Charlton Avenue East, Hamilton, Ontario L8N 4A6 Telephone: 905-522-4941. Acknowledgements: We would like to acknowledge and thank the members of the Regional Enteral Feeding Committee: Bayshore Healthcare, Care Plus, Community Rehab, Hamilton Health Sciences, Hamilton Niagara Haldimand Brant Community Care Access Centre, St. Joseph’s Home Care, St. Joseph’s Healthcare Hamilton, St. Peter’s Hospital, Victorian Order of Nurses, for
    [Show full text]